Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association-Reference-Cited by-同舟云学术

Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association

Published:2016-03-17 Issue:1 Volume:15 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Shimada Akihiro,Kimura Hideki,Oida Koji,Kanehara Hideo,Bando Yukihiro,Sakamoto Shinobu,Wakasugi Takanobu,Saga Takashi,Ito Yasuki,Kamiyama Kazuko,Mikami Daisuke,Iwano Masayuki,Hirano Tsutomu,Yoshida Haruyoshi

Funder

Grants-in-Aid for Scientific Research (c) from the Japan Society for the Promotion of Science.

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12944-016-0223-6

Reference35 articles.

1. Izem L, Morton RE. Cholesteryl ester transfer protein biosynthesis and cellular cholesterol homeostasis are tightly interconnected. J Biol Chem. 2001;276:26534–41.

2. Chapman MJ, Le Goff W, Guerin M, Kontush A. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J. 2010;31:149–64.

3. Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest. 1991;87:1559–66.